Gennex Laboratories Complete Financial Statements
GENNEX • Review detailed financials to uncover trends, confirm thesis & journal trades
9 Years of Data
2025 - 2017
Complete Financial Data Export
Export complete financial statements for Gennex Laboratories (GENNEX).
Downloads include all available records across all periods.
For market performance, see the
GENNEX stock price today
.
Profitability Ratios
Net Profit Margin
15.38%
2025 data
EBITDA Margin
20.51%
2025 data
Operating Margin
15.00%
2025 data
Return on Assets
2.34%
2025 data
Return on Equity
3.08%
2025 data
Balance Sheet Ratios
Current Ratio
10.65
2025 data
Debt to Equity
1.31
2025 data
Equity Ratio
76.17%
2025 data
Asset Turnover
0.15
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+21.9%
Year-over-Year
Net Profit Growth
+20.0%
Year-over-Year
EBITDA Growth
+33.3%
Year-over-Year
Expense Growth
+23.1%
Year-over-Year
Assets Growth
+11.3%
Year-over-Year
Equity Growth
+10.2%
Year-over-Year
Liabilities Growth
+11.3%
Year-over-Year
Operating Cash Flow Growth
+76.6%
Year-over-Year
Investing Cash Flow Growth
-94.7%
Year-over-Year
Financing Cash Flow Growth
-93.2%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Jun 2017 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 44 | 37 | 32 | 34 | 31 | 38 | 18 | 19 | 17 | 19 | 19 | 20 | 14 | 14 | 14 | 16 | 10 | 17 | 15 | 12 | 13 | 15 | 14 | 21 | 16 | 15 | 11 | 14 | 10 | 15 | 11 | 8 | 12 |
| Expenses | 32 | 39 | 29 | 26 | 29 | 24 | 33 | 12 | 17 | 11 | 17 | 18 | 19 | 13 | 13 | 12 | 14 | 9 | 15 | 14 | 11 | 12 | 14 | 13 | 19 | 15 | 14 | 10 | 14 | 9 | 14 | 10 | 7 | 11 |
| EBITDA | 8 | 6 | 7 | 6 | 4 | 7 | 5 | 5 | 1 | 5 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit Margin % | 15.00% | 5.00% | 15.00% | 18.00% | 13.00% | 15.00% | 13.00% | 29.00% | 7.00% | 31.00% | 13.00% | 7.00% | 4.00% | 6.00% | 8.00% | 13.00% | 16.00% | 16.00% | 7.00% | 10.00% | 5.00% | 6.00% | 11.00% | 7.00% | 7.00% | 8.00% | 4.00% | 7.00% | -1.00% | 8.00% | 8.00% | 8.00% | 9.00% | 7.00% |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 6 | 4 | 6 | 6 | 5 | 6 | 6 | 4 | 3 | 4 | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 6 | 3 | 5 | 5 | 5 | 5 | 5 | 3 | 2 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.21 | 0.14 | 0.22 | 0.21 | 0.16 | 0.19 | 0.22 | 0.16 | 0.19 | 0.16 | 0.16 | 0.08 | 0.10 | 0.06 | 0.07 | 0.09 | 0.15 | 0.08 | 0.06 | 0.07 | 0.02 | 0.03 | 0.10 | 0.04 | 0.02 | 0.06 | 0.02 | 0.04 | -0.02 | 0.03 | 0.07 | 0.03 | 0.03 | 0.02 |
Related Pages for Gennex Laboratories
Additional stock information and data for GENNEX
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 256 | 230 | 132 | 68 | 59 | 57 | 52 | 51 | 49 |
| Current Assets | 181 | 162 | 49 | 47 | 38 | 35 | 29 | 28 | 26 |
| Fixed Assets | 60 | 56 | 74 | 14 | 14 | 15 | 16 | 16 | 16 |
| Capital Work in Progress | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 7 | 7 | 7 | 7 | 7 | 7 |
| Other Assets | 191 | 172 | 59 | 48 | 38 | 35 | 29 | 28 | 27 |
| LIABILITIES | |||||||||
| Total Liabilities | 256 | 230 | 132 | 68 | 59 | 57 | 52 | 51 | 49 |
| Current Liabilities | 17 | 13 | 16 | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 195 | 177 | 87 | 44 | 40 | 36 | 34 | 32 | 31 |
| Share Capital | 23 | 23 | 18 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 158 | 142 | 62 | 31 | 27 | 23 | 21 | 19 | 18 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -11 | -47 | 24 | 12 | -1 | -2 | 2 | 3 | 0 |
| Investing Activities | 1 | 19 | -38 | -3 | 0 | 0 | -1 | -1 | -1 |
| Financing Activities | 5 | 74 | 21 | -2 | 2 | 0 | 1 | -2 | 1 |
| Net Cash Flow | -5 | 46 | 6 | 8 | 0 | -2 | 2 | 0 | 0 |